News

Article

PharmTech Multimedia

Cell Therapies

Eric Langer, Managing partner at BioPlan Associates, speaks with Pharmaceutical Technology about emerging trends in cell therapy.

Eric Langer, Managing Partner at BioPlan Associates, spoke with Pharmaceutical Technology about emerging trends in cell therapy. 

 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Understanding the Operational Impacts of the 15% US-EU Pharma Tariff Cap
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Related Content
B. Braun - german medical technology company, Czech branch | Image Credit: © Solarisys - stock.adobe.com
August 22nd 2025

B. Braun Medical Voluntarily Recalls Two Injections, Citing Presence of Particulate Matter

Patrick Lavery
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 22nd 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
August 22nd 2025

Johnson & Johnson Invests $2 Billion into North Carolina Facility

Susan Haigney
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
August 22nd 2025

Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain

Jill Murphy
Bio/Pharma's Tariff Response: Key Insights from Industry Survey Results
August 22nd 2025

Bio/Pharma's Tariff Response: Key Insights from Industry Survey Results

Christopher Cole
Mitragyna speciosa or kratom leaves with medicinal products in capsules and powder in white ceramic bowl and wooden table, top view | Image Credit: ©Yanawut Suntornkij - stock.adobe.com
August 22nd 2025

Kratom and the Impact of 7-OH Reclassification

Susan Haigney